Response to “Osteoporosis in Pemphigus: Steroids Are Not the Only Story”

Merve Kaya; Gülhan Aksoy Saraç; Onur Acar; Selma Emre; Akın Aktaş

doi:10.5826/dpc.1602a6352

Response to “Osteoporosis in Pemphigus: Steroids Are Not the Only Story”

Authors

Merve Kaya Health Sciences University, Ankara Bilkent City Hospital
Gülhan Aksoy Saraç Department of Dermatology, Bilkent City Hospital, Ankara, Turkey
Onur Acar Orhangazi District Health Directorate, Bursa, Turkey.
Selma Emre Department of Dermatology, Ankara Yıldırım Beyazıt University, Medical School, Ankara, Turkey.
Akın Aktaş Department of Dermatology, Ankara Yıldırım Beyazıt University, Medical School, Ankara, Turkey.

Keywords:

pemphigus, osteoporosis, Glucocorticoids

References

van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39(12):1383–89. doi:10.1093/rheumatology/39.12.1383.

Greenblatt MB, Tsai JN, Wein MN. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clin Chem. 2017;63(2):464-474. doi:10.1373/clinchem.2016.259085

Downloads

Published

2026-04-30

Issue

Vol. 16 No. 2 (2026): 2026 Vol 16, No 2 | April

Section

Letter to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

Kaya M, Gülhan Aksoy Saraç, Onur Acar, Selma Emre, Akın Aktaş. Response to “Osteoporosis in Pemphigus: Steroids Are Not the Only Story.” Dermatol Pract Concept. 2026;16(2):6352. doi:10.5826/dpc.1602a6352